Related Experiment Video

Updated: May 11, 2026

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

Targeted therapy for non-small cell lung cancer

James R Jett1, Laurie L Carr

  • 11 National Jewish Health, Denver, Colorado.

American Journal of Respiratory and Critical Care Medicine
|June 1, 2013
PubMed

Insights

New targeted therapy drugs offer improved treatment for advanced non-small cell lung cancer (NSCLC) by targeting specific driver mutations, moving beyond traditional chemotherapy.

Area of Science:

  • Oncology
  • Genetics
  • Pharmacology

Background:

  • Advanced non-small cell lung cancer (NSCLC) traditionally treated with platinum doublet chemotherapy.
  • Identification of somatic driver mutations has revolutionized NSCLC treatment strategies.
  • Targeted therapies offer a new paradigm for managing advanced NSCLC.

Purpose of the Study:

  • To discuss the two most significant targeted therapy drugs for advanced non-small cell lung cancer.
  • To highlight the role of driver mutations in guiding targeted drug selection.
  • To provide an overview of emerging treatment options for NSCLC.

Main Methods:

  • Literature review of recent advancements in targeted therapy for NSCLC.
  • Analysis of clinical data on targeted drugs impacting driver mutations.
  • Discussion of the clinical significance of identified driver mutations in NSCLC.

Main Results:

  • Two key targeted therapy drugs have emerged as crucial for NSCLC treatment.
  • These drugs specifically target identified somatic driver mutations.
  • Targeted therapy represents a significant advancement over conventional chemotherapy for certain NSCLC patients.

Conclusions:

  • Targeted therapies directed at specific driver mutations are transforming advanced non-small cell lung cancer treatment.
  • These novel drugs offer more precise and potentially effective options compared to traditional chemotherapy.
  • Further research and clinical application of these targeted agents are essential for improving patient outcomes in NSCLC.

More Related Videos

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.